AVT vs TECH · P/E 16, rev $27.63B vs P/E 65, rev $1.22B
Avnet Inc (AVT) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Avnet Inc (AVT) is a electronics & computer distribution company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported AVT revenue for 2026-06-27 was $27.63B. Net income was $334.4M. Revenue was up 24.5% from 2025-06-28 to 2026-06-27. AVT currently screens at market cap $4.72B and trailing P/E 15.8.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
AVT currently screens at market cap $4.72B and trailing P/E 15.8. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the AVT and TECH stock pages for the full models.
Not investment advice.